Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01745471 · ClinicalTrials.gov registry record

Adipose Tissue and Polycystic Ovary Syndrome (PCOS)(EIFFEL)

A clinical trial of Overweight and Polycystic Ovary Syndrome, sponsored by AdventHealth Translational Research Institute.

Active
Registry status
36
Enrollment target
1
Study location

NCT01745471 is a study of Overweight and Polycystic Ovary Syndrome that is active but no longer recruiting, run by AdventHealth Translational Research Institute. The registered enrollment target is 36 participants, below the 1,323-participant average among 197 other Overweight trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01745471, a study of Overweight and Polycystic Ovary Syndrome, is active but no longer recruiting, sponsored by AdventHealth Translational Research Institute.

ACTIVE NOT RECRUITING
Registry status
36 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to collect data to help understand why some women develop Polycystic Ovary Syndrome (PCOS) associated with decreased lower-body fat.

Study Locations (1)

Florida

  • Translational Research Institute for Metabolism and Diabetes - Orlando

Trial Details

FieldValue
Enrollment Target 36 participants
Start Date 2012-12-06
Est. Completion 2025-12

What the Registry Record Tells You About NCT01745471

The ClinicalTrials.gov registry entry for NCT01745471 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,323-participant average among 197 other Overweight trials with a reported enrollment target (97% lower). The listed sponsor is AdventHealth Translational Research Institute, which has 54 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Overweight appearing as the primary indexed condition, and to 0 interventions.

NCT01745471 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT01745471 about?

NCT01745471 is a clinical study titled "Adipose Tissue and Polycystic Ovary Syndrome (PCOS)(EIFFEL)". The purpose of this study is to collect data to help understand why some women develop Polycystic Ovary Syndrome (PCOS) associated with decreased lower-body fat.

What is the current status of trial NCT01745471?

This trial is currently active not recruiting. The enrollment target is 36 participants. The study started on 2012-12-06. Estimated completion is 2025-12.

What conditions does trial NCT01745471 study?

This clinical trial studies the following conditions: Overweight, Polycystic Ovary Syndrome, Metabolic Diseases.

Who is sponsoring clinical trial NCT01745471?

This trial is sponsored by AdventHealth Translational Research Institute, which has 54 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01745471 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Overweight

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.